BPC 157 + TB500 is a commonly discussed research peptide combination used for injury recovery and tissue repair. TB-500 mainly supports cell migration, inflammation reduction, and angiogenesis, while BPC-157 focuses on tendon, ligament, muscle, nerve, and gut healing. Together, they are believed to have synergistic effects that may accelerate recovery from soft-tissue injuries. This combination is popular in experimental and athletic communities rather than clinical medicine. It is usually administered by subcutaneous or localized injection in research contexts. Neither peptide is approved for medical use by regulatory authorities. Human clinical data, standardized dosing, and long-term safety remain limited, so use carries uncertainty.
Dosing TB-500-BPC-157:
This blend combines two well-studied regenerative peptides: BPC-157 (Body Protection Compound-157), a pentadecapeptide derived from human gastric juice with cytoprotective and wound-healing properties, and TB-500 (Thymosin Beta-4 fragment), a 43-amino-acid peptide involved in tissue repair, cell migration, and angiogenesis. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.
Reconstitute: Add 3.0 mL bacteriostatic water → 3.33 mg/mL total concentration (1.67 mg/mL of each peptide).
Typical daily range: 600–1000 mcg total blend once daily (provides 300–500 mcg of each peptide).